
Robert G. Gish, MD, discusses key studies presented at the 2006 Boston meeting, highlighting the implications of the data for your clinical practice.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Recount new clinical efficacy data on the treatment of chronic hepatitis B
- Describe predictors of response to HBV therapy
- Discuss clinical data on long-term outcomes posttreatment in HBeAg-negative chronic hepatitis B patients